Annual SG&A
$33.49 M
+$1.75 M+5.52%
31 December 2023
Summary:
Protagonist Therapeutics annual selling, general & administrative expenses is currently $33.49 million, with the most recent change of +$1.75 million (+5.52%) on 31 December 2023. During the last 3 years, it has risen by +$6.29 million (+23.15%). PTGX annual SG&A is now at all-time high.PTGX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$10.16 M
+$718.00 K+7.61%
30 September 2024
Summary:
Protagonist Therapeutics quarterly selling, general & administrative expenses is currently $10.16 million, with the most recent change of +$718.00 thousand (+7.61%) on 30 September 2024. Over the past year, it has increased by +$2.11 million (+26.15%). PTGX quarterly SG&A is now -31.87% below its all-time high of $14.91 million, reached on 31 March 2024.PTGX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.94 B
+$170.85 M+8.11%
30 September 2024
Summary:
Protagonist Therapeutics TTM selling, general & administrative expenses is currently -$1.94 billion, with the most recent change of +$170.85 million (+8.11%) on 30 September 2024. Over the past year, it has dropped by -$1.97 billion (-5878.45%). PTGX TTM SG&A is now -6958.88% below its all-time high of $42.56 million, reached on 30 September 2024.PTGX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +26.1% | -5878.4% |
| 3 y3 years | +23.1% | +39.9% | -7216.0% |
| 5 y5 years | +112.7% | +147.3% | -10000.0% |
PTGX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.1% | -31.9% | +53.2% | -35.5% | +20.6% |
| 5 y | 5 years | at high | +112.7% | -31.9% | +147.3% | -155.9% | +20.6% |
| alltime | all time | at high | +1700.6% | -31.9% | +1907.5% | -6958.9% | +20.6% |
Protagonist Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.16 M(+7.6%) | $42.56 M(+6.2%) |
| June 2024 | - | $9.44 M(-36.7%) | $40.06 M(+0.7%) |
| Mar 2024 | - | $14.91 M(+85.2%) | $39.80 M(+18.8%) |
| Dec 2023 | $33.49 M(+5.5%) | $8.05 M(+5.1%) | $33.49 M(+4.4%) |
| Sept 2023 | - | $7.66 M(-16.5%) | $32.07 M(+2.4%) |
| June 2023 | - | $9.17 M(+6.6%) | $31.31 M(+5.0%) |
| Mar 2023 | - | $8.61 M(+29.7%) | $29.83 M(-6.0%) |
| Dec 2022 | $31.74 M(+16.7%) | $6.63 M(-3.9%) | $31.74 M(-1.9%) |
| Sept 2022 | - | $6.90 M(-10.3%) | $32.37 M(-1.1%) |
| June 2022 | - | $7.69 M(-26.9%) | $32.72 M(+3.1%) |
| Mar 2022 | - | $10.52 M(+44.8%) | $31.75 M(+16.7%) |
| Dec 2021 | $27.20 M(+45.9%) | $7.26 M(+0.1%) | $27.20 M(+9.1%) |
| Sept 2021 | - | $7.26 M(+8.1%) | $24.93 M(+10.5%) |
| June 2021 | - | $6.71 M(+12.6%) | $22.57 M(+12.7%) |
| Mar 2021 | - | $5.96 M(+19.4%) | $20.03 M(+7.5%) |
| Dec 2020 | $18.64 M(+18.3%) | $4.99 M(+2.1%) | $18.64 M(+5.0%) |
| Sept 2020 | - | $4.89 M(+17.1%) | $17.75 M(+5.2%) |
| June 2020 | - | $4.18 M(-8.7%) | $16.88 M(+1.9%) |
| Mar 2020 | - | $4.58 M(+11.4%) | $16.56 M(+5.2%) |
| Dec 2019 | $15.75 M | $4.11 M(+2.3%) | $15.75 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $4.01 M(+3.9%) | $15.16 M(+4.5%) |
| June 2019 | - | $3.86 M(+2.6%) | $14.51 M(+5.0%) |
| Mar 2019 | - | $3.76 M(+7.0%) | $13.82 M(+0.9%) |
| Dec 2018 | $13.70 M(+16.3%) | $3.52 M(+4.6%) | $13.70 M(+3.4%) |
| Sept 2018 | - | $3.36 M(+5.8%) | $13.25 M(+6.2%) |
| June 2018 | - | $3.18 M(-12.7%) | $12.48 M(+0.4%) |
| Mar 2018 | - | $3.64 M(+18.6%) | $12.43 M(+5.5%) |
| Dec 2017 | $11.78 M(+69.2%) | $3.07 M(+18.4%) | $11.78 M(+4.4%) |
| Sept 2017 | - | $2.59 M(-17.0%) | $11.28 M(+9.9%) |
| June 2017 | - | $3.12 M(+4.4%) | $10.27 M(+20.3%) |
| Mar 2017 | - | $2.99 M(+16.2%) | $8.54 M(+22.6%) |
| Dec 2016 | $6.96 M(+134.9%) | $2.57 M(+63.2%) | $6.96 M(+34.0%) |
| Sept 2016 | - | $1.58 M(+13.0%) | $5.20 M(+15.9%) |
| June 2016 | - | $1.40 M(-1.4%) | $4.48 M(+15.7%) |
| Mar 2016 | - | $1.42 M(+75.1%) | $3.87 M(+30.7%) |
| Dec 2015 | $2.96 M(+59.3%) | $808.00 K(-6.4%) | $2.96 M(+37.5%) |
| Sept 2015 | - | $863.00 K(+9.8%) | $2.15 M(+66.8%) |
| June 2015 | - | $786.00 K(+55.3%) | $1.29 M(+155.3%) |
| Mar 2015 | - | $506.00 K | $506.00 K |
| Dec 2014 | $1.86 M | - | - |
FAQ
- What is Protagonist Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly SG&A year-on-year change?
- What is Protagonist Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM SG&A year-on-year change?
What is Protagonist Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of PTGX is $33.49 M
What is the all time high annual SG&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual selling, general & administrative expenses is $33.49 M
What is Protagonist Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of PTGX is $10.16 M
What is the all time high quarterly SG&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly selling, general & administrative expenses is $14.91 M
What is Protagonist Therapeutics quarterly SG&A year-on-year change?
Over the past year, PTGX quarterly selling, general & administrative expenses has changed by +$2.11 M (+26.15%)
What is Protagonist Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of PTGX is -$1.94 B
What is the all time high TTM SG&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM selling, general & administrative expenses is $42.56 M
What is Protagonist Therapeutics TTM SG&A year-on-year change?
Over the past year, PTGX TTM selling, general & administrative expenses has changed by -$1.97 B (-5878.45%)